Download interactions: TXT MITAB-2.5
Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
---|---|---|---|---|---|---|
NQO1
NAD(P)H dehydrogenase [quinone] 1 |
4 |
2 |
Small-scale |
0.891 | High |
|
P53
Cellular tumor antigen p53 |
4 |
1 |
Small-scale |
0.696 | High |
|
CHIP
E3 ubiquitin-protein ligase CHIP |
2 |
0 |
Small-scale |
0.603 | High |
|
HIF1A
Hypoxia-inducible factor 1-alpha |
2 |
0 |
Small-scale |
0.598 | High |
|
NF2L2
Nuclear factor erythroid 2-related factor 2 |
2 |
1 |
Small-scale |
0.584 | High |
|
GALT
Galactose-1-phosphate uridylyltransferase |
2 |
0 |
High-throughput |
0.580 | High |
|
SH2D3
SH2 domain-containing protein 3C |
2 |
1 |
High-throughput |
0.571 | High |
|
AKT1
RAC-alpha serine/threonine-protein kinase |
1 |
2 |
Small-scale |
0.561 | High |
|
RAF1
RAF proto-oncogene serine/threonine-protein kinase |
2 |
0 |
High-throughput |
0.559 | High |
|
GRB2
Growth factor receptor-bound protein 2 |
2 |
0 |
High-throughput |
0.547 | High |
|
CAV1
Caveolin-1 |
2 |
0 |
High-throughput |
0.547 | High |
|
PRKN
E3 ubiquitin-protein ligase parkin |
1 |
0 |
Small-scale |
0.537 | High |
|
ING1
Inhibitor of growth protein 1 |
1 |
0 |
Small-scale |
0.537 | High |
|
TRI18
E3 ubiquitin-protein ligase Midline-1 |
1 |
2 |
High-throughput |
0.536 | High |
|
P3C2A
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha |
1 |
0 |
High-throughput |
0.513 | High |
|
SHIP2
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 |
1 |
0 |
High-throughput |
0.513 | High |
|
NDUS7
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial |
1 |
0 |
High-throughput |
0.513 | High |
|
TAU
Microtubule-associated protein tau |
1 |
0 |
High-throughput |
0.513 | High |
|
TIE2
Angiopoietin-1 receptor |
1 |
0 |
High-throughput |
0.513 | High |
|
MKRN1
E3 ubiquitin-protein ligase makorin-1 |
1 |
0 |
High-throughput |
0.513 | High |
|
UB2D1
Ubiquitin-conjugating enzyme E2 D1 |
1 |
0 |
Small-scale |
0.480 | High |
|
CDC42
Cell division control protein 42 homolog |
1 |
0 |
High-throughput |
0.480 | High |
|
FOS
Protein c-Fos |
1 |
1 |
Small-scale |
0.479 | High |
|
UBE2H
Ubiquitin-conjugating enzyme E2 H |
1 |
1 |
High-throughput |
0.479 | High |
|
TRI67
Tripartite motif-containing protein 67 |
1 |
3 |
High-throughput |
0.479 | High |
|
BRD4
Bromodomain-containing protein 4 |
1 |
0 |
High-throughput |
0.458 | High |
|
BAG3
BAG family molecular chaperone regulator 3 |
1 |
0 |
High-throughput |
0.458 | High |
|
TNFA
Tumor necrosis factor |
1 |
0 |
High-throughput |
0.458 | High |
|
PARP1
Poly [ADP-ribose] polymerase 1 |
1 |
0 |
Small-scale |
0.458 | High |
|
ITA4
Integrin alpha-4 |
1 |
0 |
High-throughput |
0.458 | High |
|
TYY1
Transcriptional repressor protein YY1 |
1 |
0 |
Small-scale |
0.458 | High |
|
HSP74
Heat shock 70 kDa protein 4 |
1 |
0 |
Small-scale |
0.458 | High |
|
SOX2
Transcription factor SOX-2 |
1 |
0 |
High-throughput |
0.458 | High |
|
TERA
Transitional endoplasmic reticulum ATPase |
1 |
0 |
High-throughput |
0.458 | High |
|
TRI26
Tripartite motif-containing protein 26 |
1 |
0 |
Small-scale |
0.458 | High |
|
PSMD2
26S proteasome non-ATPase regulatory subunit 2 |
1 |
0 |
Small-scale |
0.458 | High |
|
EZH2
Histone-lysine N-methyltransferase EZH2 |
1 |
0 |
High-throughput |
0.458 | High |
|
DCA15
DDB1- and CUL4-associated factor 15 |
1 |
0 |
High-throughput |
0.458 | High |
|
SIR6
NAD-dependent protein deacylase sirtuin-6 |
1 |
0 |
Small-scale |
0.458 | High |
|
ZRAN1
Ubiquitin thioesterase ZRANB1 |
1 |
0 |
High-throughput |
0.458 | High |
|
P73
Tumor protein p73 |
1 |
1 |
Small-scale |
0.445 | High |
|
BMI1
Polycomb complex protein BMI-1 |
1 |
1 |
High-throughput |
0.445 | High |
|
VCAM1
Vascular cell adhesion protein 1 |
1 |
0 |
High-throughput |
0.426 | High |
|
KEAP1
Kelch-like ECH-associated protein 1 |
1 |
0 |
High-throughput |
0.426 | High |
|
AGR2
Anterior gradient protein 2 homolog |
1 |
0 |
High-throughput |
0.249 | Low |
|
FINC
Fibronectin |
1 |
0 |
High-throughput |
0.249 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024